ADULT;
AGITATION;
ARTICLE;
CASE REPORT;
DRUG INDICATION;
DRUG MECHANISM;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INVOLUNTARY MOVEMENT;
LIPOSUCTION;
PARADOXICAL DRUG REACTION;
PATIENT MONITORING;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
RESTLESSNESS;
SEDATION;
SIDE EFFECT;
TUMESCENT LIPOSUCTION;
United States Food and Drug Administration Website. Accessed June 27, 2008.
United States Food and Drug Administration Website Accessed June 27, 2008.
4
0041804117
Paradoxical reactions to benzodiazepines in intravenous sedation: A report of 2 cases and review of the literature
Robin C, Trieger N. Paradoxical reactions to benzodiazepines in intravenous sedation: a report of 2 cases and review of the literature. Anesth Prog 2002 49 : 128 32.
Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: A role for flumazenil?
Fulton SA, Mullen KD. Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: a role for flumazenil? Am J Gastroenterol 2000 95 : 809 11.
The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature
Weinbroum AA, Szold O, Ogorek D, et al. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 2001 18 : 789 97.